CLINICAL_TRIALS
trial_result
· 2019-05-06
Clinical Trial Update: A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis [Phase 2]
Summary
Phase 2 randomized study evaluating two concentrations of A-101 for seborrheic keratosis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Seborrheic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-06